A systematic approach to subgroup analyses in a smoking cessation trial

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The American Journal of Drug and Alcohol Abuse

• Publication date

  2015-06-11

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3109/00952990.2015.1044605PMID 26065433PMCID PMC4817346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guideline on the investigation of subgroups in confirmatory clinical trials

  2014cited by this paper
• New Directions in Information Matrix Testing: Eigenspectrum Tests

  2013influential reference
• Recent advances and future directions in causality, prediction, and specification analysis

  2013cited by this paper
• A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials.

  2013cited by this paper
• Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response.

  2013cited by this paper
• Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD.

  2012cited by this paper
• Credibility of claims of subgroup effects in randomised controlled trials: systematic review

  2012influential reference
• Damned if you do, damned if you don't: subgroup analysis and equity

  2011cited by this paper
• Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate.

  2011cited by this paper
• Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate.

  2011cited by this paper
• An Exploration of Site Effects in a Multisite Trial of OROS-Methylphenidate for Smokers with Attention Deficit/Hyperactivity Disorder

  2011cited by this paper
• Logistic regression models.

  2011cited by this paper
• OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.

  2010cited by this paper
• Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.

  2010cited by this paper
• The path to personalized medicine.

  2010cited by this paper
• Bayesian Methods in Cosmology: Model selection and multi-model inference

  2009cited by this paper
• Comparative-effectiveness research--implications of the Federal Coordinating Council's report.

  2009cited by this paper
• Influence of Methylphenidate Treatment on Smoking Behavior in Adolescent Girls With Attention-Deficit/Hyperactivity and Borderline Personality Disorders

  2009cited by this paper
• Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change

  2009cited by this paper
• A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder.

  2007influential reference
• Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?

  2006cited by this paper
• ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

  2006cited by this paper
• Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

  2005cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Nicotine effects on adults with attention-deficit/hyperactivity disorder

  2005cited by this paper
• Beck Depression Inventory-IIについての一考察

  2004cited by this paper
• A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery.

  2004cited by this paper
• Discrepancy Risk Model Selection Test theory for comparing possibly misspecified or nonnested models

  2003influential reference
• The need for dissemination of evidence-based results from research on nicotine and tobacco.

  2003cited by this paper
• The Elements of Statistical Learning

  2003cited by this paper
• Measures of abstinence in clinical trials: issues and recommendations.

  2003cited by this paper
• Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems

  2002cited by this paper
• The path to personalized medicine.

  2002cited by this paper
• Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain.

  2001cited by this paper
• Model Selection and Model Averaging

  2001cited by this paper
• Regressions by Leaps and Bounds

  2000cited by this paper
• Akaike's Information Criterion and Recent Developments in Information Complexity.

  2000influential reference
• Model selection and multi-model inference

  1998influential reference
• Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants

  1998cited by this paper
• Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder.

  1995cited by this paper
• Subset Selection in Regression

  1992cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Best subsets logistic regression

  1989cited by this paper
• Maximum Likelihood Estimation of Misspecified Models

  1982influential reference
• Information Theory and an Extension of the Maximum Likelihood Principle

  1973cited by this paper
• All Possible Regressions with Less Computation

  1971cited by this paper
• The Best Sub‐Set in Multiple Regression Analysis

  1965cited by this paper

• Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

  2022cites this paper
• Moderators of treatment response to exercise in participants with stimulant use disorder: Exploratory results from the Stimulant Reduction using Dosed Exercise (STRIDE)CTN-0037 study

  2021cites this paper
• Making causal inferences about treatment effect sizes from observational datasets

  2020cites this paper
• Statistical modeling methods: challenges and strategies

  2020cites this paper
• Evaluating heterogeneity of treatment effects

  2020cites this paper
• Differential posttreatment outcomes of methylphenidate for smoking cessation for individuals With ADHD.

  2019cites this paper
• Treatment Selection in Depression.

  2018cites this paper
• Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder

  2018cites this paper
• Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES

  2018cites this paper
• Treatment Selection: Understanding What Works For Whom In Mental Health

  2018cites this paper
• Battling Obesity : efforts in preventing knee osteoarthritis

  2017cites this paper
• Medical Graduates, Truthful and Useful Analytics With Big Data, and the Art of Persuasion.

  2017cites this paper
• Response to letter regarding “A systematic approach to subgroup analyses in a smoking cessation trial”

  2016cites this paper
• Making Causal Inferences From Observational Databases?

  2016cites this paper
• Generalized Information Matrix Tests for Detecting Model Misspecification

  2016cites this paper
• Letter re: A systematic approach to subgroup analysis in a smoking cessation trial

  2016cites this paper
• Improving the analysis and modeling of substance use

  2015influential citation